Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 59 min 10 sec ago

Neuravi Announces €19M ($21M) in Financing to Advance Innovative Minimally Invasive Stroke Therapy

Wed, 06/17/2015 - 14:07
GALWAY, Ireland--(Healthcare Sales & Marketing Network)--Neuravi, a company dedicated to improving clinical outcomes for stroke patients, announced today that it has completed a Series B financing of €19M ($21M) to advance the company’s minimally invasive ...
Devices, Neurology, Interventional, Venture Capital
Neuravi, EmboTrap, Revascularization Device, stroke

Centinel Spine(TM) Receives Allogeneic Bone Graft Indication For Its Anterior Lumbar Product Family

Wed, 06/17/2015 - 13:58
NEW YORK, June 17, 2015 -- (Healthcare Sales & Marketing Network) -- Centinel Spine™, Inc., (Centinel Spine) the pioneer of Stand-Alone, No-Profile®, Integrated Interbody™ fusion devices receive FDA clearance for its STALIF MIDLINE®, MIDLINE II™, ...
Devices, FDA, Neurosurgery, Orthopaedic
Centinel Spine, STALIF MIDLINE, MIDLINE II, MIDLINE II-Ti, spinal fusion

Kezar Life Sciences Closes $23M Series A Financing

Tue, 06/16/2015 - 15:30
Startup to Spin Out Assets From Amgen Subsidiary Onyx, Focus on Innovative New Treatments for Autoimmune Disorders SOUTH SAN FRANCISCO, Calif., June 16, 2015 -- (Healthcare Sales & Marketing Network) -- Kezar Life Sciences, a company focused on the dis...
Biopharmaceuticals, Venture Capital
Kezar Life Sciences, Immunoproteasome

Cerapedics Announces FDA Advisory Committee Panel Is Not Required for i-FACTOR(TM) PMA Approval

Tue, 06/16/2015 - 15:27
Orthobiologics company has submitted response to remaining items from PMA review of i-FACTOR™ Peptide Enhanced Bone Graft WESTMINSTER, Colo., June 16, 2015 -- (Healthcare Sales & Marketing Network) -- Cerapedics, a privately-held orthobiologics company...
Devices, Orthopaedic, FDA
Cerapedics, i-FACTOR, Bone Graft

William Annett Named Chief Executive Officer of OncoCyte Corporation

Tue, 06/16/2015 - 15:23
Appointment Brings Commercial, Operational, and Financial Expertise from Several Companies, Including Genentech and Accenture Biotechnology and Diagnostics Industry Leader to Focus on Later Stages of Clinical Trials and Commercialization of Three Non-In...
Diagnostics, Oncology, Personnel
OncoCyte, BioTime, PanC-Dx

Intellirod Spine Raises Capital and Obtains ISO Certification

Tue, 06/16/2015 - 15:20
Key milestones leading to commercialization of LOADPRO(TM) AKRON, Ohio, June 16, 2015 -- (Healthcare Sales & Marketing Network) -- Intellirod Spine, the spinal implant company developing disposable and implantable wireless RFID sensor technology for mo...
Devices, Orthopaedic, Neurosurgery, Venture Capital
Intellirod Spine, LOADPRO, ACCUVISTA

ZS Pharma Names Jeffrey Farrow as Chief Financial Officer

Tue, 06/16/2015 - 15:16
REDWOOD CITY, Calif., June 16, 2015 -- (Healthcare Sales & Marketing Network) -- ZS Pharma, Inc. (ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, li...
Biopharmaceuticals, Personnel
ZS Pharma, zirconium cyclosilicate

Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer

Tue, 06/16/2015 - 15:05
Dr. Simon Pedder to Retire MADISON, Wis., June 16, 2015 -- (Healthcare Sales & Marketing Network) -- Cellectar Biosciences, Inc. (CLRB), today announces that James V. Caruso was appointed as president and chief executive officer yesterday, replacing Dr....
Biopharmaceuticals, Oncology, Personnel
Cellectar Biosciences, phospholipid ether analog

FH Ortho Receives FDA 510(k) Clearance for Its CALCAnail(R) Orthopedic Arthrodesis Nail

Mon, 06/15/2015 - 14:13
Marks Second FDA Device Approval of 2015 CHICAGO--(Healthcare Sales & Marketing Network)--FH Ortho, maker of thoughtfully designed orthopedic devices and instruments for surgeons around the world, today announced it has received approval from The U.S. F...
Devices, Orthopaedic, FDA
FH Ortho, CALCAnail, arthrodesis nail

Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection

Mon, 06/15/2015 - 14:01
ATHLONE, Ireland, June 15, 2015 -- (Healthcare Sales & Marketing Network) -- Innocoll AG (INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of pharmaceutical products and medical devices us...
Devices, Wound Care
Innocoll AG, COACT-2, Cogenzia, diabetic foot

Spineguard Raises €2.8 ($3.1) Million of Fresh Equity Finance

Mon, 06/15/2015 - 13:00
Proceeds will be used in part to accelerate market launch of world’s first ‘smart screws’ for spine surgery PARIS & SAN FRANCISCO--(Healthcare Sales & Marketing Network)--SpineGuard (FR0011464452 – ALSGD), an innovative company that designs, develops an...
Devices, Neurosurgery, Orthopaedic, Venture Capital
SpineGuard, Dynamic Surgical Guidance, smart screw

FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication

Fri, 06/12/2015 - 15:06
Provides new option for children, ages 6 and older, with cITP Promacta was approved to treat cITP in adults in 2008, and remains the first and only oral TPO-receptor agonist that increases platelet production SAN DIEGO--(Healthcare Sales & Marketing ...
Biopharmaceuticals, FDA
Ligand Pharmaceuticals, Promacta, eltrombopag, cITP

Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer

Fri, 06/12/2015 - 14:02
RANCHO CORDOVA, Calif., June 12, 2015 -- (Healthcare Sales & Marketing Network) -- Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, announced today the appointment of Robin C. Stracey as Chief Executive Officer. Ro...
Regenerative Medicine, Personnel
Cesca Therapeutics, CellWerks, AutoXpress, MarrowXpress, Res-Q

Personal Genome Diagnostics Launches LungSelect(TM) For Non-Invasive Detection Of Clinically Actionable Mutations In Lung Cancer

Thu, 06/11/2015 - 14:57
LungSelect Identifies Clinically Relevant Somatic Alterations in Non-Small Cell Lung Cancer in Plasma with High Specificity, Eliminating the Need for Biopsy Tissue PGDx Researcher Dr. Theresa Zhang to Present LungSelect Data at GTCBio's Companion Diagno...
Diagnostics, Oncology, Product Launch
Personal Genome Diagnostics, LungSelect, NSCLC

XTuit Pharmaceuticals Closes $22 Million Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

Thu, 06/11/2015 - 14:44
Funding to Support Early Clinical Proof-of-Concept for Lead Products for Immuno-Oncology and Liver Cirrhosis/Nonalcoholic Steatohepatitis (NASH) Round led by New Enterprise Associates and joined by syndicate including founding investor Polaris Partners ...
Biopharmaceuticals, Oncology, Venture Capital
XTuit Pharmaceuticals

Biontech Launches Mammatyper(R) Breast Cancer Diagnostic Test in Europe

Thu, 06/11/2015 - 14:33
Easy-to-use molecular diagnostic test with potential to significantly improve the standard treatment of breast cancer patients BioNTech's first product to market MAINZ, Germany, June 11, 2015 -- (Healthcare Sales & Marketing Network) -- BioNTech AG,...
Diagnostics, Personalized Medicine, Oncology, Product Launch
BioNTech AG, BioNTech Diagnostics, MammaTyper, breast cancer

GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring

Wed, 06/10/2015 - 13:55
LOUISVILLE, CO--(Healthcare Sales & Marketing Network) - GlobeImmune, Inc. (GBIM) today announced that it is evaluating strategic options for the company. In conjunction with this process, the Board has authorized eliminating the majority of positions in i...
Biopharmaceuticals
GlobeImmune, Tarmogen

Panasonic Healthcare and Bayer Diabetes Care to Create Leading Global Diabetes Care Solutions Business

Wed, 06/10/2015 - 13:43
TOKYO--(Healthcare Sales & Marketing Network)--To strengthen its commitment to providing high-quality and life-enhancing products to diabetes patients globally, Panasonic Healthcare Holdings, Co., Ltd. (“PHCHD”) today announced a groundbreaking agreement w...
Biopharmaceuticals, Endocrinology, Mergers & Acquisitions
Panasonic Healthcare Holdings, Bayer AG, Bayer Diabetes Care

CMS Further Improves Reimbursement for Lutonix DCB for Outpatient Use

Tue, 06/09/2015 - 16:24
MURRAY HILL, N.J.--(Healthcare Sales & Marketing Network)--C. R. Bard, Inc. (BCR) today announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix® drug-coated balloon (DCB) under the ...
Devices, Interventional, Reimbursement
C. R. Bard, Lutonix, drug-coated balloon, PTCA

Luqa Pharmaceuticals Completes US$15M Series A Financing

Tue, 06/09/2015 - 16:20
HONG KONG, June 9, 2015 -- (Healthcare Sales & Marketing Network) --Luqa Pharmaceuticals, a China specialty care company that markets innovative solutions in dermatology and other specialty areas, announces the completion of a US$15 million round of fund ...
Biopharmaceuticals, Dermatology, Venture Capital
Luqa Pharmaceuticals

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong